A 61-year-old with nonvalvular AF and prior GI bleeding chooses LAA occlusion. After successful device implantation, what about antithrombotic therapy...

Question

A 61-year-old with nonvalvular AF and prior GI bleeding chooses LAA occlusion. After successful device implantation, what about antithrombotic therapy?

Accepted Answer

Short-term antithrombotic regimen per protocol is used post-LAAO, then transition to long-term strategy

Answer

No antithrombotics post-procedure

Answer

Warfarin lifelong in all

Answer

DAPT lifelong

Answer

Aspirin lifelong mandatory

us-abim MCQ (SBA): LAAO-Post-Procedure Management

A 61-year-old with nonvalvular AF and prior GI bleeding chooses LAA occlusion. After successful device implantation, what about antithrombotic therapy?